Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Masuda, Y.
Right arrow Articles by Demple, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Masuda, Y.
Right arrow Articles by Demple, B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 46, 30352-30359, November 13, 1998


Dynamics of the Interaction of Human Apurinic Endonuclease (Ape1) with Its Substrate and Product*

Yuji MasudaDagger , Richard A. O. Bennett, and Bruce Demple§

From the Department of Cancer Cell Biology, Harvard School of Public Health, Boston, Massachusetts 02115

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

We investigated the interaction dynamics of human abasic endonuclease, the Ape1 protein (also called Ref1, Hap1, or Apex), with its DNA substrate and incised product using electrophoretic assays and site-specific amino acid substitutions. Changing aspartate 283 to alanine (D283A) left 10% residual activity, contrary to a previous report, but complementation of repair-deficient bacteria by the D283A Ape1 protein was consistent with its activity in vitro. The D308A, D283/D308A double mutant, and histidine 309 to asparagine proteins had 22, 1, and ~0.02% of wild-type Ape1 activity, respectively. Despite this range of enzymatic activities, all the mutant proteins had near-wild-type binding affinity specific for DNA containing a synthetic abasic site. Thus, substrate recognition and cleavage are genetically separable steps. Both the wild-type and mutant Ape1 proteins bound strongly to the enzyme incision product, an incised abasic site, which suggested that Ape1 might exhibit product inhibition. The use of human DNA polymerase beta  to increase Ape1 activity by eliminating the incision product supports this conclusion. Notably, the complexes of the D283A, D308A, and D283A/D308A double mutant proteins with both intact and incised abasic DNA were significantly more stable than complexes containing wild-type Ape1, which may contribute to the lower turnover numbers of the mutant enzymes. Wild-type Ape1 protein bound tightly to DNA containing a one-nucleotide gap but not to DNA with a nick, consistent with the proposal that substrate recognition by Ape1 involves a space bracketed by duplex DNA, rather than mere flexibility of the DNA.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Base excision repair (1, 2) is a multistep process that corrects a diverse array of spontaneous and mutagen-induced DNA lesions. The process can be initiated by DNA glycosylases, which excise damaged bases to create apurinic/apyrimidinic (AP)1 sites. Modified abasic sites can arise directly from oxidative DNA-damaging agents, such as ionizing radiation (3). The AP and modified abasic sites are substrates for class II AP endonucleases, which cleave the 5' phosphodiester of both regular (hydrolytic) AP sites (4) and oxidized abasic residues (5). Excision of the lesion, DNA repair synthesis, and ligation complete the process (1, 2).

Ape1 protein is quantitatively the main AP endonuclease of human cells (6, 7). This DNA repair protein was independently named Hap1 (8) and Apex (9), and as an in vitro activator of DNA binding activity for some oxidized transcription factors, it was also named Ref1 (10-12). Ape1 protein can be separated into two functionally distinct regions, with the N-terminal domain possessing the Ref1 redox activity (10, 12) and the C-terminal domain contains the AP endonuclease activity within a 280-residue polypeptide sequence (10, 12, 13) homologous to exonuclease III of Escherichia coli (27% identity), the ExoA protein of Streptococcus pneumoniae (39% identity), the Rrp1 protein of Drosophila melanogaster (50% identity), and the Arp protein of Arabidopsis thaliana (57% identity) (4, 14).

The proteins of the Ape1/exonuclease III family exhibit a range of enzymatic activities on duplex DNA. Along with the class II AP endonuclease activity, exonuclease III possesses duplex-specific 3'-5' exonuclease activity, 3'-repair phosphodiesterase activity, 3'-phosphatase activity, and RNase H activity (15-18). Ape1 protein also has these multiple activities, but with 3'-repair diesterase, 3'-phosphatase, RNase H, and exonuclease activities 100-10,000-fold lower than its AP endonuclease activity (4, 19-21). The presence of multiple catalytic functions for exonuclease III, a relatively small (Mr ~30,000), monomeric protein suggested that a single active site catalyzes all the enzymatic reactions (22). In that model, distinct recognition elements in the protein were proposed to interact with duplex DNA 5' to the target site, and a "space" in the DNA duplex caused by a missing base or frayed 3'-end.

The crystal structure of exonuclease III has been solved, and a catalytic mechanism was proposed involving a single active site (23). The recently proposed crystal structure of Ape1/Hap1 protein (24) prompted an essentially identical proposal that involves a single active site for this enzyme. Both models involve amino acid residues that are conserved in the Ape1/exonuclease III family, and the properties of some site-specific mutant Ape1 proteins are consistent with the proposal (25, 26). In a reverse approach, Gu et al. (27) used an in vivo complementation assay to isolate mutants of the Drosophila Rrp1 protein with altered repair capacity or specificity. Some of the alterations in these proteins were mapped to conserved residues that do not correspond to functional residues proposed for exonuclease III or Ape1. One of the Rrp1 mutant proteins had diminished 3'-repair diesterase activity but normal AP endonuclease activity. Thus, either these proteins have more than one active site, or substrate specificity can be modulated independently of the catalytic activity.

We have previously addressed the mechanism of substrate recognition by Ape1 protein using electrophoretic mobility shift assay (EMSA) and footprinting methods (28). Those studies showed that Ape1 binds specifically around the abasic site in DNA and causes a pronounced distortion at the abasic site in a preincision complex (19). However, the EMSA conditions and those of others (26, 29) were not suitable for biochemical characterization, because the protein-DNA complexes were relatively unstable. Here we report improved conditions for EMSA and use the assay to monitor Ape1 binding and dissociation from an abasic substrate and the incised product. We have examined the interactions for several site-specific mutant forms of Ape1. We show here that Ape1 has a high affinity to the incised product DNA and to DNA with a one-nucleotide gap, and the several mutations that affect the catalytic activity to different degrees do not significantly affect abasic site recognition but do affect the dynamics of the protein-DNA interaction.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Strains and Plasmids

For plasmid construction, strain DH5alpha (endA1 hsdR17 (rK-mK+) supE44 thi-1 recA1 gyrA (NalR) relA1 Delta (lacZYA-argF)U169 deoR (phi 80dlacDelta (lacZ)M15)) was used (30). Strain BW528 (Delta xth nfo::kan) (31) was obtained originally from Dr. Bernard Weiss (University of Michigan Medical School). For overproduction of human Ape1 and human DNA polymerase beta  (Polbeta ) proteins, strain BL21 (DE3) (ompT lon hsdR (rB-mB-)) was used (32). The Ape1 expression plasmid, pXC53, was obtained from DuPont Merck Pharmaceutical Co., and the expression plasmid for human Polbeta was a generous gift of Dr. Stuart Linn (University of California, Berkeley, CA)

Site-directed Mutagenesis and Plasmid Construction

Construction of Mutant Ape1 Proteins-- "DeepVent" DNA polymerase (New England Biolabs, Beverly, MA) was used in the polymerase chain reaction (PCR) to generate site-specific mutations in APE1 cDNA. In the final expression constructs, any DNA products that resulted from PCRs were sequenced to verify that only the desired mutation had been introduced.

Mutant D308A (Aspartate to Alanine Substitution at Residue 308)-- Using plasmid pCW26 (7) as the template DNA, the 5'-portion of the APE1 gene was amplified with T3 (ATTAACCCTCACTAAAG) and D308A(-) primers (TAGGACAGTGAGCACTCGCGA). Likewise, the 3'-portion of the gene was amplified with T7 (AATACGACTCACTATAG) and D308A primer (TCGCGAGTGCTCACTGTCCTA) in a separate reaction. The reaction products were then isolated, mixed together, and PCR-amplified with the T7 and T3 primers to generate a complete APE1 cDNA with the desired site-specific mutation. The final PCR product was cut with EcoRI and subcloned into Bluescript KS (Stratagene, La Jolla, CA) at the EcoRI site. Note that the sequence of D308A primer had been designed to change two amino acid residues, although the final plasmid had in fact only one mutation, D308A.

Mutants H309N (Histidine to Asparagine Substitution at Residue 309) and D283A (Aspartate to Alanine Substitution at Residue 283)-- Mutagenesis was exactly as for D308A, except that the H309N (CGGCAGTGATAACTGTCCTAT) or D283A (GTTGGTTGGCGCCTTGCTTAC) primer and the H309N(-) (ATAGGACAGTTATCACTGCCG) or D283A(-) (GTAAGCAAGGCGCCAACCAAC) primer were used to mutate the gene. The intermediate PCR products were amplified with hAPE15NcoI (CAGCTGCCATGGGGTTCG) and hAPE13HindIII (TCTCTGAAGCTTGTTTAAAG) primers to generate the entire gene with the desired site-specific mutation. The final PCR product was cut with NcoI and HindIII and subcloned into NcoI/HindIII-digested pSE380 (Invitrogen, Carlsbad, CA).

Mutant D283A/D308A (Aspartate to Alanine Substitutions at Residues 283 and 308)-- The technique described for generating the D308A substitution was used to construct this double mutant, except that the template DNA for the PCR was the single mutant D283A in pSE380. The primers D308A and D308A(-) were used to create the second site-specific mutation.

To construct expression plasmids for the mutant portion, the 238-base pair PstI-HindIII fragment encompassing the 3'-portion of APE1 cDNA from pXC53 was replaced with the corresponding PstI-HindIII fragment from the mutagenized plasmids. For in vivo complementation tests, a XbaI-HindIII fragment containing the entire APE1 DNA from pXC53 or its derivatives was inserted downstream of the arabinose-regulated promoter of pBAD22A (obtained from The Cloning Vector Collection of the National Institute of Genetics, Shizuoka, Japan).

In Vivo Complementation Test

Strain BW528 was transformed by pBAD22A or the derivatives carrying the wild-type or mutant APE1 gene. The resulting strains were tested for their ability to form single colonies by streak-dilution on LB agar plates (33) containing 0.025% methyl methanesulfonate (MMS) and 0.2% L-arabinose. The colony-forming ability was checked after incubation for 24 h at 37 °C.

DNA Substrates

Poly[d(A-T)] containing [alpha -32P,uracil-3H]dUMP at a frequency of one per 500 nucleotides was synthesized as described by Levin and Demple (34), except that the [alpha -32P]dUTP was prepared from labeled dCTP (Andotek, Irvine, CA) by deamination with dCTP deaminase (35) (kindly provided by Dr. Bernard Weiss, University of Michigan Medical School). After the reaction, more than 95% of dCTP had been converted to dUTP, as determined using thin layer chromatography on polyethyleneimine cellulose (36).

A 51-mer synthetic oligonucleotide (37) containing a tetrahydrofuran residue (51F), a uracil (51U), or a cytosine at position 22 (51C) and the related oligonucleotides (see Fig. 6A) were purchased from Operon Technologies Inc. (Alameda, CA). The concentration of high pressure liquid chromatography-purified oligonucleotides was determined by measuring absorbance at 260 nm (38). To generate a double-stranded substrate, 100 pmol of oligonucleotide was 5'-end-labeled with [gamma -32P]ATP using T4 polynucleotide kinase (New England Biolabs, Beverly, MA) and then annealed to the complementary oligonucleotide (see Fig. 6A). After precipitation with ethanol, the amount of DNA recovered was determined by monitoring the recovered radioactivity.

To prepare incised 51F, the double-stranded oligonucleotide (100 pmol) was treated with 12.5 pmol of Ape1 in a 100-µl reaction (50 mM Tris-HCl (pH 8.4), 10 mM MgCl2, and 0.2 mg/ml BSA) at 37 °C for 10 min. The reaction was stopped by adding 5 µl of 0.5 M EDTA. After the reaction, 98% of substrate had been converted to the incised form (data not shown). The DNA was sequentially extracted with phenol-chloroform and chloroform and then precipitated with ethanol.

A substrate with a single AP site was prepared according to Bennett et al. (39), except that the Ape1 reaction buffer was used (50 mM HEPES-KOH (pH 7.5), 50 mM KCl, 0.1 mg/ml BSA, 10 mM MgCl2, and 0.05% Triton X-100). After treatment with recombinant E. coli uracil-DNA glycosylase (a generous gift of Dr. Dale Mosbaugh, Oregon State University), the reaction mixture was used directly for incision assays.

Protein Purification

To purify the recombinant Ape1 proteins, expression was accomplished by addition of isopropyl beta -D-thiogalactopyranoside when the bacterial cultures had reached an absorbance at 600 nm to 0.5, and the incubation was continued for 90 min according to Marians (40). Cell lysates (fraction I) were prepared as described by Hupp and Kaguni (41). The cell lysate was fractionated at a 55% saturation of ammonium sulfate, and the remaining soluble proteins were then precipitated at 80% saturation of ammonium sulfate. The proteins were resuspended in Buffer A (50 mM HEPES-KOH (pH 7.5), 1 mM EDTA, 0.1 mM dithiothreitol, 10% (v/v) glycerol) containing 100 mM KCl and dialyzed against the same buffer (fraction II). Fraction II was applied to a 20-ml phosphocellulose (Whatman P11) column and then eluted with a linear gradient of 100-750 mM KCl in Buffer A. The peak fractions containing Ape1 were pooled and dialyzed against Buffer A containing 100 mM KCl, (fraction III). Fraction III was applied to a MonoS 5/5 column (Amersham Pharmacia Biotech) and then eluted with a linear gradient of 100-250 mM KCl in Buffer A. The peak fractions containing Ape1 were pooled and concentrated by dialysis against Buffer A containing 200 mM KCl and 20% polyethylene glycol (average molecular weight, 8000) (fraction IV). Fraction IV was applied to a Superose-12 column (Amersham Pharmacia Biotech), which yielded a first, symmetrical peak corresponding to Ape1 protein and the AP endonuclease activity, and a second peak corresponding to residual lysozyme from the cell lysis procedure (41).

For Polbeta purification, expression of the protein and preparation of lysate (fraction I) were performed basically the same as for Ape1 purification. After dialysis against Buffer B (50 mM Tris-HCl (pH 8.0), 1 mM EDTA, 0.1 mM dithiothreitol, and 10% (v/v) glycerol) containing 100 mM KCl, fraction I was applied to a 60-ml phosphocellulose (Whatman P11) column and then eluted with a linear gradient of 100-800 mM KCl in Buffer B. The peak fractions containing active Polbeta were pooled and dialyzed against Buffer B containing 100 mM KCl, (fraction II). Fraction II was applied to a 1-ml heparin column (Amersham Pharmacia Biotech) and eluted with a linear gradient of 50-750 mM KCl in Buffer B. Fractions containing active Polbeta were pooled. Analysis of these fractions by SDS-PAGE indicated that they contained only a single protein detectable by silver staining (data not shown).

Protein concentrations were determined by the Bio-Rad protein assay (Bio-Rad), based on the method of Bradford (42), using BSA (Amersham Pharmacia Biotech) as the standard.

DNA Binding Assays by EMSA

The following binding methods were adapted from the protocols of Wilson et al. (28), Ng and Marians (43), and Hendrickson and Schleif (44). Modification of the binding conditions of Wilson et al. (28) involved exploring the pH range 7.5-8.8 with different buffers and a range of KCl concentrations up to 50 mM NaCl (data not shown); however, the most important factors in the improved electrophoretic resolution were the reduction of the concentration of EDTA and omission of glycerol from the buffer.

For binding measurements, reaction mixtures (10 µl) in 50 mM Tris-HCl (pH 8.4), 1 mM EDTA (pH 8.0), and 0.2 mg/ml BSA containing 51F DNA (1 nM) were mixed with proteins as indicated in the figure legends. The mixtures were incubated on ice for 10 min and loaded on a prerunning 8% polyacrylamide gel (80:1 acrylamide:bisacrylamide). The electrophoresis buffer contained 6 mM Tris-HCl (pH 7.8), 5 mM sodium acetate, and 0.1 mM EDTA (43), and the gels were subjected to a constant voltage of 8 V/cm applied for 2 h at 4 °C. Following gel electrophoresis, the gels were dried and autoradiographed at -80 °C. The amount of DNA present in each band was quantified using a Molecular Imager system (Bio-Rad).

To follow dissociation, binding reaction mixtures (100 µl) containing 1 nM 51F DNA and 7.8 nM Ape1 protein were incubated on ice for 10 min. The subsequent steps were carried out at 0-4 °C using equipment prechilled to 4 °C. At time 0, 10-µl samples were removed, mixed with 1 µl of a 1-µM unlabeled 51F stock, and incubated for various times on ice before being loaded on a prerunning gel to separate free DNA from the Ape1-DNA complexes.

Product Depletion Assay

To deplete the Ape1 reaction product from the reaction mixture, we used human Polbeta and a 51-mer oligonucleotide (100 nM) containing a natural AP site as the substrate. The concentration of proteins used is indicated in the figure legends. After the incision reactions, the AP site was treated with NaBH4 (140 mM) to reduce and stabilize it against spontaneous beta -elimination (45). After inactivation of the enzymes by heating at 80 °C for 1 min, the DNA was analyzed on a 20% polyacrylamide gel containing 8 M urea. The amount of DNA present in each band was quantified using a Molecular Imager system (Bio-Rad).

Other Enzyme Assays

To monitor AP endonuclease activity during purification, poly[d(A-T)] containing [alpha -32P,uracil-3H]dUMP was used as a substrate. Just before use, the polymer was treated with uracil-DNA glycosylase (kindly provided by Dr. Dale Mosbaugh, Oregon State University) at 37 °C for 1.5 h under standard assay conditions. The AP endonuclease assays contained DNA with 1.8 pmol of AP sites in 25 µl, and the reactions were initiated by addition of an enzyme sample (<= 2 µl), followed by incubation at 37 °C for 5 min. The reactions were stopped by addition of 25 µl of stop solution (0.45 N NaOH, 25 mM EDTA) and heating for 45 min at 65 °C. The amount of incised AP sites was determined as the acid-soluble, Norit-nonadsorbed radioactivity following treatment at alkaline pH; beta -elimination of nonincised AP sites does not liberate the 32P label in Norit-nonadsorbable form (34). One unit of AP endonuclease was defined as the amount of activity that cleaves 1 pmol of AP sites per min.

To monitor the Polbeta activity during purification, a hairpin-structured oligonucleotide DNA (46) was used as a substrate. Assays contained 50 pmol of substrate DNA in buffer, 25 µl of 50 mM HEPES-KOH (pH 7.5), 50 mM KCl, 0.1 mg/ml BSA, 10 mM MgCl2, 0.5 mM dithiothreitol, and 100 µM each of [alpha -32P]dTTP, dGTP, dCTP, and dATP and were initiated by the addition of an enzyme sample (<= 2 µl) and incubation at 37 °C for 5 min. The reactions were stopped by addition of 25 µl of 50 mM EDTA, and 5-µl samples were spotted on DE81 paper (Whatman), which was washed three times with 0.5 M Na2HPO4. The amount of incorporated dTMP was determined as the radioactivity retained on the paper (38).

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Purification of Mutant Ape1 Proteins-- The site-specifically mutated Ape1 proteins were purified following overexpression in E. coli strain BL21 (DE3). After induction of the D283A and D308A mutant proteins, the crude extracts (fraction I) containing these proteins displayed significantly higher AP endonuclease activity than extracts of the control strain (data not shown), which indicated that both the D283A and D308A proteins retain substantial enzymatic activity. This result seemed to contrast with the data of Barzilay et al. (25), who reported a D283A mutant protein that had ~2000-fold reduced activity. Therefore, we purified the mutant proteins very carefully, and both the AP endonuclease activity and the amount of the induced Mr 37,000 protein were monitored during all purification steps.

In contrast to the above, for the D283A/D308A double-mutant and H309N proteins, no increase was detected in the total AP endonuclease activity in crude extracts of cells after protein induction, even though substantial amounts of the induced recombinant proteins were detected by SDS-PAGE (data not shown). Thus, only the induced Mr 37,000 protein could be monitored during the purification of the D283A/D308A and H309N proteins. In the final step of the H309N purification, the leading edge of a bacterial AP endonuclease peak introduced <5% contaminating activity (data not shown).

Analysis of these preparations by SDS-PAGE and staining with Coomassie Brilliant Blue (Fig. 1) or silver (data not shown) indicated that they contained only a single predominant polypeptide (>= 95%) with Mr ~37,000 as expected for this protein of 35,500 Da (7). Interestingly, the two proteins containing the D283A mutation migrated slightly faster in the gel. Table I summarizes the enzymatic activity of the purified proteins.


View larger version (82K):
[in this window]
[in a new window]
 
Fig. 1.   SDS-PAGE analysis of purified Ape1 proteins. Each lane contained 1.5 µg of protein. Electrophoresis was performed using a 12% polyacrylamide gel, followed by Coomassie Blue staining according to Sambrook et al. (38). M, marker proteins, in descending order of Mr: 97,400, 66,000, 45,000, 31,000, 21,500, and 14,500 (from top to bottom). Lane 1, wild-type Ape1 recombinant protein; lane 2, H309N protein; lane 3, D283A protein; lane 4, D308A protein; lane 5, D283A/D308A protein.

                              
View this table:
[in this window]
[in a new window]
 
Table I
AP endonuclease activity of purified wild-type and mutant Ape1 proteins

The enzymatic activity of the mutant proteins was also addressed by complementation of the nfo- xth- E. coli strain BW528 (31). This strain has <5% of the normal AP endonuclease activity and is highly sensitive to MMS, but the wild-type APE1 gene can restore MMS resistance to it (7). Consistent with the activities measured in vitro, the D283A and D308A mutant APE1 genes under inducing conditions restored MMS resistance in BW528, whereas the genes containing the D283A/D308A double mutation, or the H309N single mutation, did not.2

Binding of Ape1 to 51F DNA-- We previously (28) showed that an EMSA allows the identification of specific complexes between wild-type Ape1 and DNA containing an abasic site. However, these complexes are evidently unstable, as indicated by the "smear" of DNA migrating in gels between the protein-DNA complex and the free DNA (28). This material likely represents protein-DNA complexes that dissociated during electrophoresis. Thus, the assay probably underestimates the amount of DNA bound by protein. The binding and electrophoresis conditions were therefore modified (see under "Experimental Procedures") to allow the free DNA and the DNA-Ape1 complexes to be separated cleanly by electrophoresis (Fig. 2A, panel a). Nonspecific DNA binding by the Ape1 proteins was estimated by using 51C DNA as the substrate, which revealed only small amounts of protein-DNA complexes with any of the proteins (Fig. 2B). Small amounts of these nonspecific complexes were also observed for 51F DNA incubated with the highest levels of Ape1 protein (see, for example, Fig. 2A, panel d). Thus, the modified EMSA detects predominantly damage-specific binding by Ape1.


View larger version (43K):
[in this window]
[in a new window]
 
Fig. 2.   Specific binding of wild-type and mutant proteins to an abasic site. A and B, autoradiographs of EMSA analysis with 51F DNA (A) or 51C DNA (B). Reaction mixtures (10 µl) containing 1 nM of labeled DNA and the indicated concentration of protein were incubated and analyzed as described under "Experimental Procedures." Filled and open arrowheads indicate the positions of the DNA-Ape1 complexes and the free DNA, respectively. Gels: a, wild-type Ape1; b, D283A protein; c, D308A protein; d, D283A/D308A protein; e, H309N protein. C, quantitation of EMSA results. The band intensities were measured by a Molecular Imager system, and the fraction of DNA bound was calculated as amount of complex divided by total DNA and normalized to 100%. wt, wild-type.

The quantitative binding curves for 51F and the various Ape1 proteins are shown in Fig. 2C. For all five proteins, the amount of protein-DNA complex formed was proportional to the protein concentration up to 4 nM (Fig. 2C). This result allowed us to estimate the relative binding affinities of wild-type and mutant Ape1 proteins (Table II). Surprisingly, all the mutant proteins showed high affinity for 51F in this assay, with quantitative values very close to that for wild-type Ape1 protein (Fig. 2C; Table II). The D308A and D283A/D308A proteins showed slightly higher affinity for the abasic DNA than did wild-type Ape1, and the H309N mutant had only ~2-fold reduced affinity (Table II), even though its AP endonuclease activity was markedly reduced (Table I). Thus, the defects in the D283A/D308A and H309N proteins do not seem to influence substrate recognition, in contrast to an inactive Ape1 mutant protein that was reported to lose both activity and damage-specific DNA binding (26). This result shows that AP-specific binding and enzymatic activity can be separated by certain amino acid substitutions.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Binding affinity of wild-type and mutant Ape1 proteins for damaged DNA and stability of the protein-DNA complexes

Dissociation of Ape1 from 51F DNA-- Dissociation of an enzyme from its DNA substrate prior to cleavage can be an important factor in limiting its catalytic activity. We studied the dissociation of preformed complexes of the Ape1 proteins and labeled 51F DNA by adding a large excess of unlabeled 51F DNA (see under "Experimental Procedures"). The vast majority of any dissociated Ape1 protein will bind to this unlabeled DNA rather than rebind to the small portion of labeled DNA. Samples were taken at various times after adding the competitor DNA and analyzed by EMSA. Fig. 3A shows that at 0 °C, Ape1-DNA complexes were converted to free DNA during incubation with the unlabeled 51F substrate in a time-dependent manner. The quantitative dissociation curves allowed us to determine the half-lives of the protein-DNA complexes in the EMSA procedure (Fig. 3B). For wild-type Ape1 protein, this value was 50 s. Previously, we developed a filter binding assay to measure the half-life of Ape1 complexes with DNA containing an abasic site, and the new value agrees quite well with the previous result (28). Surprisingly, the half-lives of the F-DNA complexes with the D283A, D308A, and D283A/D308A proteins were considerably longer than for wild-type Ape1 (5, 9, and 7 min, respectively). In contrast, the half-life of the complex with H309N protein was too short to measure in this assay, because the majority of the protein had dissociated within 10 s (Fig. 3B; Table II).


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 3.   Kinetics of dissociation of Ape1 proteins from an AP site. A, autoradiographs of EMSA analysis. The reaction mixtures contained 1 nM of labeled 51F DNA and 7.8 nM of the indicated Ape1 protein and were incubated for 10 min to allow complex formation. The dissociation reactions were started by adding a 100-fold molar excess of unlabeled 51F DNA. After incubation for the indicated times, the remaining protein-DNA complex was resolved as described under "Experimental Procedures." Time 0 represents no added competitor DNA. The filled and open arrowheads indicate the positions of the DNA-Ape1 complexes and the free DNA, respectively. Gels: a, wild-type Ape1; b, H309N protein; c, D308A protein; d, D283A protein; e, D283A/D308A protein. B, quantitation of EMSA results. The analysis was performed as described in the legend to Fig. 2. wt, wild-type.

Binding of Ape1 Proteins to Incised 51F DNA-- The catalytic activity of Ape1 may be limited by interaction with its reaction product, DNA containing an incised abasic site, but this question had not been explicitly studied. We approached this issue by using incised 51F DNA as a binding substrate. EMSA using the incised 51F DNA showed that both the wild-type and mutant Ape1 proteins had high affinity for incised 51F DNA (Fig. 4A, panels a-d). For the wild-type, D283A, D308A, and D283A/D308A proteins, we estimate 50% binding of incised 51F DNA at 4 nM Ape1 protein (Table II). The dissociation of Ape1 proteins from complexes with 51F DNA was also measured by EMSA, again using unlabeled, nonincised 51F DNA as a competitor (Fig. 5) For the wild-type, D283A, and D283A/D308A proteins, the half-lives were 35, 50, and 65 s, respectively (Table II); for the D308A protein, the half-life was 130 s (Table II). Thus, under our conditions, wild-type Ape1 and all but one of the mutant proteins bound the endonuclease cleavage product with affinities very close to those for the nonincised abasic DNA substrate.


View larger version (43K):
[in this window]
[in a new window]
 
Fig. 4.   Specific binding of wild-type and mutant Ape1, or of Polbeta , to incised abasic sites. A, analysis by EMSA; autoradiographs are shown. Reaction mixtures (10 µl) contained 1 nM of labeled, preincised 51F DNA and protein as indicated. After incubation to allow complex formation, EMSA and analysis were conducted as described under "Experimental Procedures." The filled and open arrowheads indicate the positions of the DNA-Ape1 complexes and the free DNA, respectively. The asterisk represents the position of a small fraction of single-stranded incised 51F. Gels: a, wild-type Ape1; b, D283A protein; c, D308A protein; d, D283A/D308A protein; e, H309N protein; f, Polbeta . B, quantitation of binding to incised DNA. Analysis was conducted as described in the legend to Fig. 2; the band indicated by the asterisk was omitted from the analysis. wt, wild-type.


View larger version (48K):
[in this window]
[in a new window]
 
Fig. 5.   Kinetics of dissociation of Ape1 proteins from an incised abasic site. A, dissociation followed by EMSA; autoradiographs are shown. Reaction mixtures contained 1 nM of labeled, preincised 51F and 7.8 nM of protein and were incubated for 10 min to allow complex formation. The dissociation reactions were started by adding a 100-fold molar excess of unlabeled 51F DNA. After incubation for the indicated times, the remaining protein-DNA complex was resolved as described under "Experimental Procedures" and loaded onto a polyacrylamide gel. Time 0 represents no added competitor DNA. The filled and open arrowheads indicate the positions of the DNA-Ape1 complexes and the free DNA, respectively. The asterisk represents the position of a small fraction of single-stranded incised 51F. Gels: a, wild-type Ape1; b, D283A protein; c, D308A protein; d, D283A/D308A protein. B, quantitation of the dissociation reaction. The analysis was carried out as described in the legend to Fig. 2, except that the band indicated by the asterisk (see Fig. 4 legend) was omitted from the calculations. wt, wild-type.

Incised 51F DNA also bound Polbeta tightly (Fig. 4, panel f), even though this material is not a substrate for deoxyribose-phosphate excision by the beta -elimination activity of the polymerase (45). The affinity of Polbeta for incised 51F DNA was such that a higher protein concentration (estimated ~12 nM; see Fig. 4B) was required for 50% binding by Polbeta than by Ape1 (compare with Table II).

High-affinity Binding of Ape1 Protein to DNA Containing a One-nucleotide Gap-- The high affinity of Ape1 for the incised F site suggested that the enzyme might bind generally to nicked or gapped structures in DNA. To test this idea, we generated duplex oligonucleotides with a one-nucleotide gap at the same position as the F residue in 51F, a nick at this position, or protruding 3'- or 5'-single-stranded regions; the structures are shown in Fig. 6A. In EMSA experiments, Ape1 bound the structure of the duplex oligonucleotides with a one-nucleotide gap with affinity similar to that for incised or intact F sites (Fig. 6B). In contrast, Ape1 did not have high affinity for the structure with a nick or the 5'-single-stranded or 3'-single-stranded structures (Fig. 6B). We have not explored the gap size-dependence of Ape1 binding affinity.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 6.   Specific binding of wild-type Ape1 to one-nucleotide gapped DNA. A, structures of the DNA substrates used for EMSA. The positions labeled with alpha -32P are indicated as P*. The 5'-ends of oligonucleotides at the site of a gap or nick were phosphorylated with a molar excess of unlabeled ATP using T4 polynucleotide kinase. B, autoradiographs of EMSA analysis. Reaction mixtures (10 µl) contained 1 nM of labeled DNA substrate and the indicated concentration of wild-type Ape1 protein, and were incubated as described in the legend to Fig. 2. The filled and open arrowheads indicate the positions of DNA-Ape1 complexes and free DNA, respectively. The DNA substrates used are indicated to the left of each gel panel; the concentration of Ape1 protein is shown along the top. 51-Gap, duplex oligonucleotides with a one-nucleotide gap at the same position as the F residue in 51F; 51-Nick, a nick at this position; 3'-ss and 5'-ss, protruding 3'- and 5'-single-stranded regions, respectively.

Effect of the Product on the Nicking Reaction in Solution-- The high affinity of Ape1 protein for the incised product and for one-nucleotide gapped DNA suggested that the enzyme might exhibit product inhibition, although such an effect has not been reported. One possibility is that Ape1 has high affinity for the incised tetrahydrofuran (F) abasic site, but not for an incised hydrolytic AP site. Because the latter moieties can undergo degradation during electrophoresis (45), we performed steady-state kinetic studies using a substrate with a glycosylase-generated AP site.

In Ape1 incision reactions, the kinetics exhibited a short linear range restricted to <30% incision (Fig. 7A, open circles). We obtained essentially the identical result when we used the 51F substrate (data not shown). The nonlinearity observed as the incision reactions proceeded could result from competitive inhibition by the incised product. If the incision product is a competitive inhibitor, then the depletion of the product by the deoxyribose-phosphatase and DNA polymerase activities of Polbeta (45) might enhance the reaction by Ape1. Indeed, in the presence of Polbeta and dCTP, Ape1 incision kinetics showed an expanded linear range (Fig. 7A, closed circles), although Polbeta cannot incise abasic sites (Fig. 7A, closed triangle) (45). The same effect of Polbeta was seen for the D283A and D308A proteins (Fig. 7, B and C). This result is consistent with the results from EMSA using 51F, which show that the Ape1 proteins have affinity for incised 51F DNA.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 7.   Kinetics of the Ape1 nicking reaction. Reaction mixtures with (closed symbols) or without (open symbols) 250 fmol of Polbeta were mixed with the indicated Ape1 protein (6.3 fmol) (circles) or buffer (triangles) at time 0 under the standard assay conditions containing 0.1 mM dCTP in a 25-µl final volume. Two-µl samples were removed at the indicated times and mixed with 5 µl of a stop solution containing 60% formamide and 20 mM EDTA. The products were analyzed on a 20% polyacrylamide gel containing 8 M urea. The intensities of intact and incised DNA bands were measured by a Molecular Imager system, and the amount of incision was quantitated. The first time point was at 15 s after addition of the Ape1 proteins. Essentially the same result was obtained in two independent experiments, one of which is shown; we estimate the measurement errors in these determinations to be <= 5%. wt, wild-type.

To confirm that Polbeta actually depletes the Ape1 reaction products, the amount of the substrate, the product, and the DNA fragment extended one nucleotide by Polbeta were measured at various concentrations of Polbeta (Fig. 8A). In the presence of dCTP, the incised product (21-mer) was converted to a 22-mer by the gap-filling activity of Polbeta (Fig. 8, A and B). The total amount of incised DNA (21-mer + 22-mer) increased in a manner dependent on the Polbeta concentration up to ~15 nM and then continued to increase with a lower Polbeta dependence up to a plateau. The beginning of this plateau (at 50-100 nM Polbeta ) was identical to concentration at which almost all the incised product (21-mer) had been converted to the 22-mer form (Fig. 8B). The total amount of incision (21-mer + 22-mer) in this single time point experiment was inversely correlated with the amount of the Ape1-incised compound (21-mer) present (Fig. 8B). On the other hand, in the absence of dCTP, the smaller enhancing effect of Polbeta on the Ape1 reaction might not be enzymatic (Fig. 8C), but rather the Ape1-incised DNA molecules may be sequestered through binding by high concentrations of Polbeta . These results are consistent with the result from EMSA that Ape1 has high affinity for its incised product.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 8.   Effect of Polbeta on the Ape1 nicking reaction. A, nicking assay showing an autoradiograph. Reactions (containing 100 nM substrate and the indicated concentration of Polbeta , with or without 0.1 mM dCTP) were initiated by adding wild-type Ape (3.1 fmol). After incubation for 10 min at 37 °C, the reactions were stopped by addition of 2 µl of 250 mM EDTA and analyzed on a 20% polyacrylamide gel containing 8 M urea. B, quantitation of reaction products in the presence of dCTP. Each band of the reaction in the presence of dCTP was measured by a Molecular Imager system and calculated as a fraction of the total DNA. C, the effect of dCTP. The incision products were quantified as for B.


    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Our studies have addressed the substrate and product binding dynamics of Ape1, the predominant AP endonuclease of human cells. The results show that the incised product of the AP endonuclease reaction is a competitive inhibitor for Ape1 and that the next enzyme of the base excision repair pathway, DNA polymerase beta , can capture the Ape1 product to overcome this limitation. Furthermore, analysis of catalytically impaired mutant Ape1 proteins demonstrated that substrate binding and the chemical steps of phosphodiester cleavage are separable by certain mutations.

We created four different mutant proteins by site-directed mutagenesis. These altered enzymes had reduced AP endonuclease activity between 22 and ~0.02% that of wild-type Ape1. Unexpectedly, the D283A protein was quite active (10% of wild-type), although Barzilay et al. (25) reported that this mutation markedly reduced the activity (~2000-fold) and concluded that aspartate 283 was critical for catalysis. Repeated DNA sequencing and independent subcloning efforts showed that only the D283A change was introduced by our procedure. The activity of the D283A protein was not derived from contaminating bacterial AP endonuclease: first, the AP endonuclease activity was dependent on expression of the human protein; second, during purification, the activity copurified with the induced Mr 37,000 protein; and third, the D283A mutant cDNA restored resistance to MMS in an xth- nfo- strain of E. coli. We found that the D283A protein could aggregate under low-salt conditions (Buffer A containing 25 mM KCl), which is one possible explanation for the dramatically divergent results. Alternatively, the D283A derivative generated by Barzilay et al. (25) may contain an unintended second mutation. Regardless, aspartate 283 contributes to activity in Ape1 but is not essential.

We found that Ape1 protein has high affinity for incised abasic sites, which was not detected in previous studies (28, 39). The previous EMSA conditions may have been too stringent for this detection, because the complex of Ape1 and the incised abasic site is less stable than the complex of Ape1 and an intact abasic site (compare Fig. 2 with Fig. 4). However, the binding determinants for incised abasic sites might overlap with those for uncleaved abasic residues, because the wild-type, D283A, D308A, and D283A/D308A proteins had identical affinity. The much lower affinity of the H309N protein for incised abasic sites compared with the other Ape1 derivatives could reflect an important role of histidine-309 in product binding specifically, as this protein has near-wild-type affinity for the substrate (an intact abasic site).

Interestingly, the stability of the Ape1 DNA complexes varied among the wild-type and the various mutant proteins. The slower dissociation of the D283A, D308A, and D283A/D308A proteins from the intact abasic site than from the incised lesion indicates that the preincision complex is stabilized by the continuous DNA structure and perhaps by substrate contacts within the active site. In a current model (23, 24), the aspartate residue that was replaced in the D283A and D283A/D308A proteins is postulated to act as general base. Without this aspartate residue, the histidine residue might stabilize the preincision complex. In fact, the unincised 51F DNA complex with the H309N protein had a much lower stability, consistent with loss of an important contact. The model of Gorman et al. (24) suggests that histidine 309 interacts with the 5'-phosphate bond of the abasic site through a water molecule. Structural studies of these mutant proteins, particularly in complexes with DNA, would be useful.

What does Ape1 protein recognize specifically in DNA? We showed previously that neither the deoxyribose of the AP site itself nor the base opposite the AP site is necessary for incision (19). Indeed, strong binding by Ape1 can occur when no residue is present at all, as shown with the 51-Gap substrate (Fig. 6). A mere nick was insufficient to allow Ape1 to bind stably, but Strauss et al. (29) showed that Ape1 protein has high affinity for a 3'-incised abasic site resulting from beta -elimination. We found that Ape1 binds tightly to a 5'-incised AP site, which together with the foregoing observations indicates a strong binding determinant for the gap or "space" itself, as originally suggested by Weiss (22) for exonuclease III. Beyond this conclusion, the 3'-OH and 5'-phosphate moieties of the gapped substrate are evidently not important binding determinants. One observation that seems at first inconsistent with this model is the report that Ape1 can incise a duplex oligonucleotide 5' to a 3,N4-benzetheno-2'-deoxycytidine residue (47). However, molecular modeling suggests that the local structure at the adduct site is similar to that of an AP site (48), with the adducted base shifted away from the base in the opposite strand.

Although the EMSA approach is not suitable for determination of rate constants, we were able to show in steady-state reactions that Polbeta enhances Ape1 activity. This observation supports the suggestion from EMSA experiments that the incised DNA product would be a competitive inhibitor by strongly binding to Ape1 protein. The activating effect of Polbeta on Ape1 is most likely due to its gap-filling activity, as the activation was most effective when a nucleoside triphosphate was present to allow DNA synthesis. These experiments also extended the range of experiments in which the F analog and a hydrolytic AP site are handled identically by Ape1 (19, 28, 39).

We previously proposed a model that Ape1 protein loads Polbeta onto the incised abasic site by specific protein-protein interactions and in the process enhances the deoxyribose-phosphate excision reaction of Polbeta (5, 39). We demonstrated here that Ape1 protein has high affinity for the product of the DNA Polbeta excision reaction, a one-nucleotide-gapped DNA. Although it is unknown how often one-nucleotide gaps arise in DNA in vivo, this binding activity of Ape1 protein for one-nucleotide gaps might promote repair of those gaps by allowing Ape1 to act as a molecular matchmaker (49) for Polbeta and gapped DNA.

    ACKNOWLEDGEMENTS

We thank Dr. Dale Mosbaugh (Oregon State University) for supplying the uracil DNA glycosylase, Dr. Bernard Weiss (University of Michigan Medical School) for supplying the dCTP deaminase, and Dr. Stuart Linn (University of California, Berkeley, CA) for providing the polymerase beta  expression plasmid. We are grateful to Dr. Yongjie Xu for critical suggestions and help with the figures and to Donny Wong for helpful comments on the manuscript.

    FOOTNOTES

* This work was supported by Grants GM40000, CA71993, and ES03926 from the National Institutes of Health.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Present address: Dept. of Developmental Biology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan.

§ To whom correspondence should be addressed. E-mail: bdemple{at}hsph.harvard.edu.

The abbreviations used are: AP, apurinic/apyrimidinic; F, tetrahydrofuran; 51F, 51-mer double-strand DNA containing a tetrahydrofuran residue at position 22; EMSA, electrophoretic-mobility-shift assay; Polbeta , DNA polymerase beta ; PCR, polymerase chain reaction; MMS, methyl methanesulfonate; BSA, bovine serum albumin; PAGE, polyacrylamide gel electrophoresis.

2 Y. Masuda, R. A. O. Bennett, and B. Demple, unpublished data.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Seeberg, E., Eide, L., and Bjorås, M. (1995) Trends Biochem. Sci. 20, 391-397[CrossRef][Medline] [Order article via Infotrieve]
  2. Wilson, S. H. (1998) Mutat. Res. 407, 203-215[Medline] [Order article via Infotrieve]
  3. von Sonntag, C. (1987) The Chemical Basis of Radiation Biology, Taylor and Francis, London
  4. Demple, B., and Harrison, L. (1994) Annu. Rev. Biochem. 63, 915-948[CrossRef][Medline] [Order article via Infotrieve]
  5. Xu, Y.-J., Kim, E. Y., and Demple, B. (1998) J. Biol. Chem. 273, in press
  6. Chen, D. S., Herman, T., and Demple, B. (1991) Nucleic Acids Res. 19, 5907-5914[Abstract/Free Full Text]
  7. Demple, B., Herman, T., and Chen, D. S. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 11450-11454[Abstract/Free Full Text]
  8. Robson, C. N., and Hickson, I. D. (1991) Nucleic Acids Res. 19, 5519-5523[Abstract/Free Full Text]
  9. Seki, S., Hatsushika, M., Watanabe, S., Akiyama, K., Nagao, K., and Tsutsui, K. (1992) Biochim. Biophys. Acta 1131, 287-299[Medline] [Order article via Infotrieve]
  10. Xanthoudakis, S., Miao, G. G., and Curran, T. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 23-27[Abstract/Free Full Text]
  11. Xanthoudakis, S., Miao, G., Wang, F., Pan, Y. C., and Curran, T. (1992) EMBO J. 11, 3323-3335[Medline] [Order article via Infotrieve]
  12. Walker, L. J., Robson, C. N., Black, E., Gillespie, D., and Hickson, I. D. (1993) Mol. Cell. Biol. 13, 5370-5376[Abstract/Free Full Text]
  13. Izumi, T., and Mitra, S. (1998) Carcinogenesis 19, 525-527[Abstract/Free Full Text]
  14. Barzilay, G., and Hickson, I. D. (1995) BioEssays 17, 713-719[CrossRef][Medline] [Order article via Infotrieve]
  15. Richardson, C., and Kornberg, A. (1964) J. Biol. Chem. 239, 242-250[Free Full Text]
  16. Richardson, C., Lehman, I., and Kornberg, A. (1964) J. Biol. Chem. 239, 251-258[Free Full Text]
  17. Demple, B., Johnson, A., and Fung, D. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 7731-7735[Abstract/Free Full Text]
  18. Bernelot-Moens, C., and Demple, B. (1989) Nucleic Acids Res. 17, 587-600[Abstract/Free Full Text]
  19. Wilson, D. M., III, Takeshita, M., Grollman, A. P., and Demple, B. (1995) J. Biol. Chem. 270, 16002-16007[Abstract/Free Full Text]
  20. Barzilay, G., Walker, L. J., Robson, C. N., and Hickson, I. D. (1995) Nucleic Acids Res. 23, 1544-1550[Abstract/Free Full Text]
  21. Suh, D., Wilson, D. M., III, and Povirk, L. F. (1997) Nucleic Acids Res. 25, 2495-2500[Abstract/Free Full Text]
  22. Weiss, B. (1976) J. Biol. Chem. 251, 1896-1901[Abstract/Free Full Text]
  23. Mol, C. D., Kuo, C. F., Thayer, M. M., Cunningham, R. P., and Tainer, J. A. (1995) Nature 374, 381-386[CrossRef][Medline] [Order article via Infotrieve]
  24. Gorman, M. A., Morera, S., Rothwell, D. G., de La Fortelle, E., Mol, C. D., Tainer, J. A., Hickson, I. D., and Freemont, P. S. (1997) EMBO J. 16, 6548-6558[CrossRef][Medline] [Order article via Infotrieve]
  25. Barzilay, G., Mol, C. D., Robson, C. N., Walker, L. J., Cunningham, R. P., Tainer, J. A., and Hickson, I. D. (1995) Nat. Struct. Biol. 2, 561-568[CrossRef][Medline] [Order article via Infotrieve]
  26. Rothwell, D. G., and Hickson, I. D. (1996) Nucleic Acids Res. 24, 4217-4221[Abstract/Free Full Text]
  27. Gu, L., Huang, S. M., and Sander, M. (1994) J. Biol. Chem. 269, 32685-32692[Abstract/Free Full Text]
  28. Wilson, D. M., III, Takeshita, M., and Demple, B. (1997) Nucleic Acids Res. 25, 933-939[Abstract/Free Full Text]
  29. Strauss, P. R., Beard, W. A., Patterson, T. A., and Wilson, S. H. (1997) J. Biol. Chem. 272, 1302-1307[Abstract/Free Full Text]
  30. Woodcock, D. M., Crowther, P. J., Doherty, J., Jefferson, S., DeCruz, E., Noyer-Weidner, M., Smith, S. S., Michael, M. Z., and Graham, M. W. (1989) Nucleic Acids Res. 17, 3469-3478[Abstract/Free Full Text]
  31. Cunningham, R. P., Saporito, S. M., Spitzer, S. G., and Weiss, B. (1986) J. Bacteriol. 168, 1120-1127[Abstract/Free Full Text]
  32. Studier, F. W., Rosenberg, A. H., Dunn, J. J., and Dubendorff, J. W. (1990) Methods Enzymol. 185, 60-89[Medline] [Order article via Infotrieve]
  33. Miller, J. (1992) A Short Course in Bacterial Genetics, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  34. Levin, J. D., and Demple, B. (1990) Nucleic Acids Res. 18, 5069-5075[Abstract/Free Full Text]
  35. Wang, L., and Weiss, B. (1992) J. Bacteriol. 174, 5647-5653[Abstract/Free Full Text]
  36. Shlomai, J., and Kornberg, A. (1978) J. Biol. Chem. 253, 3305-3312[Free Full Text]
  37. Singhal, R. K., Prasad, R., and Wilson, S. H. (1995) J. Biol. Chem. 270, 949-957[Abstract/Free Full Text]
  38. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  39. Bennett, R. A. O., Wilson, D. M., III, Wong, D., and Demple, B. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 7166-7169[Abstract/Free Full Text]
  40. Marians, K. J. (1995) Methods Enzymol. 262, 507-521[Medline] [Order article via Infotrieve]
  41. Hupp, T. R., and Kaguni, J. M. (1993) J. Biol. Chem. 268, 13128-13136[Abstract/Free Full Text]
  42. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254[CrossRef][Medline] [Order article via Infotrieve]
  43. Ng, J. Y., and Marians, K. J. (1996) J. Biol. Chem. 271, 15642-15648[Abstract/Free Full Text]
  44. Hendrickson, W., and Schleif, R. F. (1984) J. Mol. Biol. 178, 611-628[CrossRef][Medline] [Order article via Infotrieve]
  45. Matsumoto, Y., and Kim, K. (1995) Science 269, 699-702[Abstract/Free Full Text]
  46. Maki, H., and Kornberg, A. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 4389-4392[Abstract/Free Full Text]
  47. Hang, B., Chenna, A., Fraenkel-Conrat, H., and Singer, B. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 13737-13741[Abstract/Free Full Text]
  48. Hang, B., Rothwell, D. G., Sagi, J., Hickson, I. D., and Singer, B. (1997) Biochemistry 36, 15411-15418[CrossRef][Medline] [Order article via Infotrieve]
  49. Sancar, A., and Hearst, J. E. (1993) Science 259, 1415-1420[Abstract/Free Full Text]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
V. M. Castillo-Acosta, L. M. Ruiz-Perez, W. Yang, D. Gonzalez-Pacanowska, and A. E. Vidal
Identification of a residue critical for the excision of 3'-blocking ends in apurinic/apyrimidinic endonucleases of the Xth family
Nucleic Acids Res., April 1, 2009; 37(6): 1829 - 1842.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. Chen, F.-Y. Dupradeau, D. A. Case, C. J. Turner, and J. Stubbe
DNA oligonucleotides with A, T, G or C opposite an abasic site: structure and dynamics
Nucleic Acids Res., January 17, 2008; 36(1): 253 - 262.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. L. Maher and L. B. Bloom
Pre-steady-state Kinetic Characterization of the AP Endonuclease Activity of Human AP Endonuclease 1
J. Biol. Chem., October 19, 2007; 282(42): 30577 - 30585.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Masuda and K. Kamiya
Role of Single-stranded DNA in Targeting REV1 to Primer Termini
J. Biol. Chem., August 25, 2006; 281(34): 24314 - 24321.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Takeuchi, T. Ruike, R.-i. Nakamura, K. Shimanouchi, Y. Kanai, Y. Abe, A. Ihara, and K. Sakaguchi
Drosophila DNA Polymerase {zeta} Interacts with Recombination Repair Protein 1, the Drosophila Homologue of Human Abasic Endonuclease 1
J. Biol. Chem., April 28, 2006; 281(17): 11577 - 11585.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-S. Sung, M. S. DeMott, and B. Demple
Long-patch Base Excision DNA Repair of 2-Deoxyribonolactone Prevents the Formation of DNA-Protein Cross-links with DNA Polymerase {beta}
J. Biol. Chem., November 25, 2005; 280(47): 39095 - 39103.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Ahn, J. A. Harrigan, F. E. Indig, D. M. Wilson III, and V. A. Bohr
Regulation of WRN Helicase Activity in Human Base Excision Repair
J. Biol. Chem., December 17, 2004; 279(51): 53465 - 53474.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Maita, T. Anzai, H. Aoyagi, H. Mizuno, and H. Fujiwara
Crystal Structure of the Endonuclease Domain Encoded by the Telomere-specific Long Interspersed Nuclear Element, TRAS1
J. Biol. Chem., September 24, 2004; 279(39): 41067 - 41076.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Wong and B. Demple
Modulation of the 5'-Deoxyribose-5-phosphate Lyase and DNA Synthesis Activities of Mammalian DNA Polymerase {beta} by Apurinic/Apyrimidinic Endonuclease 1
J. Biol. Chem., June 11, 2004; 279(24): 25268 - 25275.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-C. Shen and L. A. Loeb
Mutations in the {alpha}8 Loop of Human APE1 Alter Binding and Cleavage of DNA Containing an Abasic Site
J. Biol. Chem., November 21, 2003; 278(47): 46994 - 47001.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Wong, M. S. DeMott, and B. Demple
Modulation of the 3'->5'-Exonuclease Activity of Human Apurinic Endonuclease (Ape1) by Its 5'-incised Abasic DNA Product
J. Biol. Chem., September 19, 2003; 278(38): 36242 - 36249.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Priet, J.-M. Navarro, N. Gros, G. Querat, and J. Sire
Functional Role of HIV-1 Virion-associated Uracil DNA Glycosylase 2 in the Correction of G:U Mispairs to G:C Pairs
J. Biol. Chem., February 7, 2003; 278(7): 4566 - 4571.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
H.-D. Junker, S. T. Hoehn, R. C. Bunt, V. Marathius, J. Chen, C. J. Turner, and J. Stubbe
Synthesis, characterization and solution structure of tethered oligonucleotides containing an internal 3'-phosphoglycolate, 5'-phosphate gapped lesion
Nucleic Acids Res., December 15, 2002; 30(24): 5497 - 5508.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. S. DeMott, E. Beyret, D. Wong, B. C. Bales, J.-T. Hwang, M. M. Greenberg, and B. Demple
Covalent Trapping of Human DNA Polymerase beta by the Oxidative DNA Lesion 2-Deoxyribonolactone
J. Biol. Chem., March 1, 2002; 277(10): 7637 - 7640.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. T. Hoehn, C. J. Turner, and J. Stubbe
Solution structure of an oligonucleotide containing an abasic site: evidence for an unusual deoxyribose conformation
Nucleic Acids Res., August 15, 2001; 29(16): 3413 - 3423.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
A. E. Vidal, I. D. Hickson, S. Boiteux, and J. P. Radicella
Mechanism of stimulation of the DNA glycosylase activity of hOGG1 by the major human AP endonuclease: bypass of the AP lyase activity step
Nucleic Acids Res., March 15, 2001; 29(6): 1285 - 1292.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
H. Yang, W. M. Clendenin, D. Wong, B. Demple, M. M. Slupska, J.-H. Chiang, and J. H. Miller
Enhanced activity of adenine-DNA glycosylase (Myh) by apurinic/apyrimidinic endonuclease (Ape1) in mammalian base excision repair of an A/GO mismatch
Nucleic Acids Res., February 1, 2001; 29(3): 743 - 752.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. W. Hill, T. K. Hazra, T. Izumi, and S. Mitra
Stimulation of human 8-oxoguanine-DNA glycosylase by AP-endonuclease: potential coordination of the initial steps in base excision repair
Nucleic Acids Res., January 15, 2001; 29(2): 430 - 438.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
D. G. Rothwell, B. Hang, M. A. Gorman, P. S. Freemont, B. Singer, and I. D. Hickson
Substitution of Asp-210 in HAP1 (APE/Ref-1) eliminates endonuclease activity but stabilises substrate binding
Nucleic Acids Res., June 1, 2000; 28(11): 2207 - 2213.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. A. O. Bennett
The Saccharomyces cerevisiae ETH1 Gene, an Inducible Homolog of Exonuclease III That Provides Resistance to DNA-Damaging Agents and Limits Spontaneous Mutagenesis
Mol. Cell. Biol., March 1, 1999; 19(3): 1800 - 1809.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Masuda, R. A. O. Bennett, and B. Demple
Rapid Dissociation of Human Apurinic Endonuclease (Ape1) from Incised DNA Induced by Magnesium
J. Biol. Chem., November 13, 1998; 273(46): 30360 - 30365.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Unk, L. Haracska, R. E. Johnson, S. Prakash, and L. Prakash
Apurinic Endonuclease Activity of Yeast Apn2 Protein
J. Biol. Chem., July 14, 2000; 275(29): 22427 - 22434.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Masuda, M. Takahashi, N. Tsunekuni, T. Minami, M. Sumii, K. Miyagawa, and K. Kamiya
Deoxycytidyl Transferase Activity of the Human REV1 Protein Is Closely Associated with the Conserved Polymerase Domain
J. Biol. Chem., April 27, 2001; 276(18): 15051 - 15058.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. K. Kenny, F. Mendez, M. Sandigursky, R. P. Kureekattil, J. D. Goldman, W. A. Franklin, and R. Bases
Heat Shock Protein 70 Binds to Human Apurinic/Apyrimidinic Endonuclease and Stimulates Endonuclease Activity at Abasic Sites
J. Biol. Chem., March 16, 2001; 276(12): 9532 - 9536.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Masuda, Y.
Right arrow Articles by Demple, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Masuda, Y.
Right arrow Articles by Demple, B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement